$ELOX Eloxx Pharmaceuticals, Inc. Insider Trading Week 20/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Eloxx Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Eloxx Pharmaceuticals, Inc. in week 20/2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Option Exercise | A | 2.00 | 410 | 820 | 13,804 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Option Exercise | A | 2.00 | 23 | 46 | 762 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Option Exercise | A | 4.00 | 8,185 | 32,740 | 276,047 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Option Exercise | A | 4.00 | 244 | 976 | 8,180 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Option Exercise | A | 3.00 | 7,411 | 22,233 | 249,974 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Option Exercise | A | 2.00 | 13,394 | 26,788 | 13,394 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Option Exercise | A | 2.00 | 739 | 1,478 | 739 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Option Exercise | A | 4.00 | 267,862 | 1,071,448 | 267,862 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Option Exercise | A | 4.00 | 7,936 | 31,744 | 7,936 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Option Exercise | A | 3.00 | 242,563 | 727,689 | 242,563 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Grant | A | 0.00 | 31,396 | 0 | 1,058,970 | 1 M to 1.1 M (+3.06 %) |
| May 20 2014 | SVON | Sevion Therapeutic ... | SMIDER VAUGHN | Chief Scientific Of ... | Grant | A | 0.00 | 1,027,574 | 0 | 1,058,970 | 31.4 K to 1.1 M (+3,272.95 %) |
| May 20 2014 | SVON | Sevion Therapeutic ... | GRAZIANO JAMES JOSEPH | Chief Technology Of ... | Option Exercise | A | 2.00 | 1,361 | 2,722 | 1,361 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | GRAZIANO JAMES JOSEPH | Chief Technology Of ... | Option Exercise | A | 2.00 | 76 | 152 | 76 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | GRAZIANO JAMES JOSEPH | Chief Technology Of ... | Option Exercise | A | 4.00 | 27,211 | 108,844 | 27,211 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | GRAZIANO JAMES JOSEPH | Chief Technology Of ... | Option Exercise | A | 4.00 | 807 | 3,228 | 807 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | GRAZIANO JAMES JOSEPH | Chief Technology Of ... | Option Exercise | A | 3.00 | 24,641 | 73,923 | 24,641 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | GRAZIANO JAMES JOSEPH | Chief Technology Of ... | Grant | A | 0.00 | 104,386 | 0 | 104,386 | 0 to 104.4 K |
| May 20 2014 | SVON | Sevion Therapeutic ... | FROST PHILLIP MD ET AL | Director | Option Exercise | A | 2.00 | 11,688 | 23,376 | 11,688 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | FROST PHILLIP MD ET AL | Director | Option Exercise | A | 2.00 | 646 | 1,292 | 646 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | FROST PHILLIP MD ET AL | Director | Option Exercise | A | 4.00 | 233,696 | 934,784 | 567,029 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | FROST PHILLIP MD ET AL | Director | Option Exercise | A | 4.00 | 6,927 | 27,708 | 6,927 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | FROST PHILLIP MD ET AL | Director | Option Exercise | A | 3.00 | 211,626 | 634,878 | 544,959 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | FROST PHILLIP MD ET AL | Director | Grant | A | 0.00 | 896,504 | 0 | 1,563,170 | 666.7 K to 1.6 M (+134.48 %) |
| May 20 2014 | SVON | Sevion Therapeutic ... | RIOS MIGUEL DE LOS | VP- Research | Option Exercise | A | 2.65 | 113,082 | 299,667 | 113,082 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | Isabelle Warren John | Director | Grant | A | 0.00 | 5,000 | 0 | 6,038 | 1 K to 6 K (+481.70 %) |
| May 20 2014 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Grant | A | 0.00 | 5,000 | 0 | 13,149 | 8.1 K to 13.1 K (+61.36 %) |
| May 20 2014 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Option Exercise | A | 2.65 | 7,500 | 19,875 | 43,056 | |
| May 20 2014 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 2.65 | 7,500 | 19,875 | 52,405 |